Edition:
United States

TherapeuticsMD Inc (TXMD.OQ)

TXMD.OQ on NASDAQ Stock Exchange Global Select Market

6.16USD
21 May 2018
Change (% chg)

$-0.14 (-2.22%)
Prev Close
$6.30
Open
$6.37
Day's High
$6.45
Day's Low
$6.10
Volume
439,321
Avg. Vol
471,850
52-wk High
$7.00
52-wk Low
$3.83

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 3.77 -0.113
FY 2017 Dec '17 4.12 -0.101
Sep '17 4.42 -0.071
Jun '17 4.25 -0.097
Mar '17 3.99 -0.107
FY 2016 Dec '16 4.49 -0.116
Sep '16 5.54 -0.127
Jun '16 4.40 -0.107
Mar '16 4.93 -0.107
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 7 4.30 4.68 3.80 --
Quarter Ending Sep-18 7 6.27 13.50 3.90 --
Year Ending Dec-18 7 25.54 34.34 17.00 127.97
Year Ending Dec-19 7 162.38 275.50 90.00 298.58
Earnings (per share)
Quarter Ending Jun-18 7 -0.12 -0.09 -0.15 --
Quarter Ending Sep-18 7 -0.13 -0.08 -0.16 --
Year Ending Dec-18 7 -0.52 -0.34 -0.63 -0.11
Year Ending Dec-19 7 -0.14 0.04 -0.35 0.27
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 28.57 32.53
P/E High - Last 5 Yrs. -- 41.44 47.11
P/E Low - Last 5 Yrs. -- 23.40 24.61
Beta 1.35 0.80 0.79
Price to Sales (TTM) 79.75 4.06 8.85
Price to Book (MRQ) 12.72 3.49 4.22
Price to Tangible Book (MRQ) 12.69 4.40 5.79
Price to Cash Flow (TTM) -- 19.79 21.98
% Owned Institutions 73.38 1.27 2.39

Dividends

  Company industry sector
Dividend Yield -- 1.80 1.67
Dividend Yield - 5 Year Avg -- 0.79 0.80
Dividend 5 Year Growth Rate -- 2.73 4.12
Payout Ratio(TTM) -- 16.85 17.66

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -5.32 3.97 5.06
Sales (TTM) vs TTM 1 Yr. Ago -10.03 10.12 12.43
Sales - 5 Yr. Growth Rate 34.46 7.45 8.11
EPS (MRQ) vs Qtr. 1 Yr. Ago -5.37 37.00 32.52
EPS (TTM) vs TTM 1 Yr. Ago 16.80 -- --
EPS - 5 Yr. Growth Rate -- 7.09 8.54
Capital Spending - 5 Yr. Growth Rate 24.86 8.30 8.79

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 7.51 2.52 2.50
Current Ratio (MRQ) 7.61 3.58 3.56
LT Debt to Equity (MRQ) 0.00 10.34 12.76
Total Debt to Equity (MRQ) 0.00 12.69 15.69
Interest Coverage (TTM) -- 40.07 34.90

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 84.24 55.56 54.71
Gross Margin - 5 Yr. Avg. 78.82 52.71 52.74
EBITD Margin (TTM) -487.97 -- --
EBITD - 5 Yr. Avg -415.09 18.51 15.91
Operating Margin (TTM) -489.32 13.07 -1.83
Operating Margin - 5 Yr. Avg. -415.74 14.25 11.18
Pre-Tax Margin (TTM) -483.96 13.35 0.25
Pre-Tax Margin - 5 Yr. Avg. -417.73 14.52 11.38
Net Profit Margin (TTM) -483.96 9.76 -3.16
Net Profit Margin - 5 Yr. Avg. -417.73 10.80 7.67
Effective Tax Rate (TTM) -- 22.46 31.64
Effective Tax Rate - 5 Yr. Avg. -- 23.90 24.59

Efficiency

  Company industry sector
Revenue/Employee (TTM) 95,755 836,134,495 726,901,196
Net Income/Employee (TTM) -463,415 97,299,163 84,519,443
Receivable Turnover (TTM) 3.67 5.53 5.67
Inventory Turnover (TTM) 1.76 2.49 3.53
Asset Turnover (TTM) 0.13 0.87 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -64.82 10.46 9.99
Return on Assets - 5 Yr. Avg. -81.22 11.69 11.11
Return on Investment (TTM) -73.67 13.08 12.63
Return on Investment - 5 Yr. Avg. -92.99 15.12 14.39
Return on Equity (TTM) -73.67 14.80 14.50
Return on Equity - 5 Yr. Avg. -93.47 16.36 15.75
  1 Year 3 Year 5 Year
Sales % -13.32 3.74 34.46
EPS (TTM) % 18.34 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for TherapeuticsMD Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 10.33 8.59 83 6
13 Week 12.90 13.70 83 12
26 Week 7.69 2.37 63 11
52 Week 46.51 27.76 83 10
YTD 4.30 2.79 68 9
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 73.42%
# of Holders: 192
Total Shares Held: 159,006,744
3 Mo. Net Change: -1,216,502
# New Positions: 26
# Closed Positions: 27
# Increased Positions: 81
# Reduced Positions: 78
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.